Skip to content

Single-Laser PVI: Single-encirclement Laserballoon Ablation for Pulmonary Veins Isolation

Single-Laser PVI: Single-encirclement Laserballoon Ablation for Pulmonary Veins Isolation

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04165642
Acronym
SingleLaser
Enrollment
82
Registered
2019-11-18
Start date
2019-10-01
Completion date
2023-07-05
Last updated
2023-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assessment of Procedural Times of Laser Ballon Ablation, Assessment of Safety of Laser Balloon Ablation

Keywords

laser ballon ablation, laser ballon, pulmonary vein isolation, atrial fibrillation, AF ablation

Brief summary

To assess the efficacy of laser balloon ablation of atrial fibrillation (AF) without verification of electrical isolation of pulmonary veins using implantable loop recorder. This is a prospective and single-center study. A targeted number of 82 patients suffering from paroxysmal or persistent AF, indicated to undergo catheter ablation will be included. The study will consist of: i) patient enrolment, ii) treatment phase, and iii) 1-year follow-up phase. The duration of the study is expected to be 24 months, from first patient enrolment to last patient follow up.

Detailed description

This is a prospective and single-center study. A targeted number of 82 patients suffering from paroxysmal or persistent AF, indicated to undergo catheter ablation will be included. The study will consist of: i) patient enrolment, ii) treatment phase, and iii) 1-year follow-up phase. The duration of the study is expected to be 24 months, from first patient enrolment to last patient follow up. In a recent meta-analysis including 1188 patients, free from arrhythmic recurrences at 12 months after a single ablative procedure with a laser balloon and without continuous monitoring with ILR was 74%1. Assuming that the approach without post-ablative verification of pulmonary vein isolation and continuous monitoring with ILR can lead to a 60% success rate at 12 months, 80 patients are required to have an 80% probability to observe a level of 2-code significance of 0.05 in an exponential model with the log rank test. With an estimated loss of data (patients lost to follow-up, protocol deviations and incomplete data) of 5%, the total number of patients to be enrolled is 82. Subject screening and enrolment will be carried out for approximately 12 months. The study will continue up to 12 months after last patient enrolment, dependent on the rate of enrolment and the regulatory timeline (as applicable).

Interventions

OTHERLaser ballon ablation for Pulmonary vein isolation

The patients indicated to AF ablation procedure will be treated with laser balloon ablation without verification of electrical isolation of pulmonary veins using implantable loop recorder and/or Holter monitoring

Sponsors

IRCCS Policlinico S. Donato
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years

Inclusion criteria

To participate in this clinical subject, the subject must meet all of the following inclusion criteria: * Age between 18 and 85 years * Paroxysmal or persistent AF * Patients AF who have indications for the first time ablation procedure according to the ESC / EHRA recommendations (European Society of Cardiology / European Heart Rhythm Association). * Ability to provide written informed consent for study participation and be willing and able to comply with the study evaluations and follow up schedule

Exclusion criteria

Subjects are not eligible for clinical study participation if they meet any of the following

Design outcomes

Primary

MeasureTime frameDescription
Success rate at 1 year12 months after ablationFree from AF, atrial tachycardia and flutter documented with ILR or Holter ECG monitorwithout antiarrhythmic drugs.

Secondary

MeasureTime frameDescription
Procedural and 1-year complications related to the ablation procedure.during the procedure and 12 months after ablationProcedural and 1-year complications related to the ablation procedure.
inducibility of AF after the proceduresDuring the procedureprogrammed atrial stimulation before and after isoproterenol
AF Burden12 months after ablationAssessment of AF burden by holter monitoring or implantable loop recorder

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026